Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Upregulation of PD-L1 via HMGB1-activated IRF3 and NF-kB contributes to UV radiation-induced immune suppression.

Wang W, Chapman NM, Zhang B, Li M, Fan M, Laribee RN, Zaidi MR, Pfeffer LM, Chi H, Wu ZH.

Cancer Res. 2019 Feb 8. pii: canres.3134.2018. doi: 10.1158/0008-5472.CAN-18-3134. [Epub ahead of print]

PMID:
30737234
2.

The Interferon-Gamma Paradox in Cancer.

Zaidi MR.

J Interferon Cytokine Res. 2019 Jan;39(1):30-38. doi: 10.1089/jir.2018.0087. Epub 2018 Nov 9.

PMID:
30388040
3.

Spatiotemporal Labeling of Melanocytes in Mice.

Preston S, Aras S, Zaidi MR.

Int J Mol Sci. 2018 May 15;19(5). pii: E1469. doi: 10.3390/ijms19051469. Review.

4.

STIM1 (c)AMPs up melanogenesis.

Soboloff J, Gligorijevic B, Zaidi MR.

EMBO J. 2018 Mar 1;37(5). pii: e99047. doi: 10.15252/embj.201899047. Epub 2018 Feb 15. No abstract available.

PMID:
29449324
5.

Interferon-γ Signaling in Melanocytes and Melanoma Cells Regulates Expression of CTLA-4.

Mo X, Zhang H, Preston S, Martin K, Zhou B, Vadalia N, Gamero AM, Soboloff J, Tempera I, Zaidi MR.

Cancer Res. 2018 Jan 15;78(2):436-450. doi: 10.1158/0008-5472.CAN-17-1615. Epub 2017 Nov 17.

6.

TAMeless traitors: macrophages in cancer progression and metastasis.

Aras S, Zaidi MR.

Br J Cancer. 2017 Nov 21;117(11):1583-1591. doi: 10.1038/bjc.2017.356. Epub 2017 Oct 24. Review.

7.

Genetically engineered mouse models of melanoma.

Pérez-Guijarro E, Day CP, Merlino G, Zaidi MR.

Cancer. 2017 Jun 1;123(S11):2089-2103. doi: 10.1002/cncr.30684. Review.

8.

The heterogeneity of store-operated calcium entry in melanoma.

Hooper R, Zaidi MR, Soboloff J.

Sci China Life Sci. 2016 Aug;59(8):764-9. doi: 10.1007/s11427-016-5087-5. Epub 2016 Jul 14. Review.

9.

Programming of donor T cells using allogeneic δ-like ligand 4-positive dendritic cells to reduce GVHD in mice.

Mochizuki K, Meng L, Mochizuki I, Tong Q, He S, Liu Y, Purushe J, Fung H, Zaidi MR, Zhang Y, Reshef R, Blazar BR, Yagita H, Mineishi S, Zhang Y.

Blood. 2016 Jun 23;127(25):3270-80. doi: 10.1182/blood-2015-05-644476. Epub 2016 May 3.

10.

mTORC1 activation blocks BrafV600E-induced growth arrest but is insufficient for melanoma formation.

Damsky W, Micevic G, Meeth K, Muthusamy V, Curley DP, Santhanakrishnan M, Erdelyi I, Platt JT, Huang L, Theodosakis N, Zaidi MR, Tighe S, Davies MA, Dankort D, McMahon M, Merlino G, Bardeesy N, Bosenberg M.

Cancer Cell. 2015 Jan 12;27(1):41-56. doi: 10.1016/j.ccell.2014.11.014.

11.

Hippo-independent activation of YAP by the GNAQ uveal melanoma oncogene through a trio-regulated rho GTPase signaling circuitry.

Feng X, Degese MS, Iglesias-Bartolome R, Vaque JP, Molinolo AA, Rodrigues M, Zaidi MR, Ksander BR, Merlino G, Sodhi A, Chen Q, Gutkind JS.

Cancer Cell. 2014 Jun 16;25(6):831-45. doi: 10.1016/j.ccr.2014.04.016. Epub 2014 May 29.

12.

A polymorphism in IRF4 affects human pigmentation through a tyrosinase-dependent MITF/TFAP2A pathway.

Praetorius C, Grill C, Stacey SN, Metcalf AM, Gorkin DU, Robinson KC, Van Otterloo E, Kim RS, Bergsteinsdottir K, Ogmundsdottir MH, Magnusdottir E, Mishra PJ, Davis SR, Guo T, Zaidi MR, Helgason AS, Sigurdsson MI, Meltzer PS, Merlino G, Petit V, Larue L, Loftus SK, Adams DR, Sobhiafshar U, Emre NC, Pavan WJ, Cornell R, Smith AG, McCallion AS, Fisher DE, Stefansson K, Sturm RA, Steingrimsson E.

Cell. 2013 Nov 21;155(5):1022-33. doi: 10.1016/j.cell.2013.10.022.

13.

HMGA2 is a driver of tumor metastasis.

Morishita A, Zaidi MR, Mitoro A, Sankarasharma D, Szabolcs M, Okada Y, D'Armiento J, Chada K.

Cancer Res. 2013 Jul 15;73(14):4289-99. doi: 10.1158/0008-5472.CAN-12-3848. Epub 2013 May 30.

14.

Melanoma induction by ultraviolet A but not ultraviolet B radiation requires melanin pigment.

Noonan FP, Zaidi MR, Wolnicka-Glubisz A, Anver MR, Bahn J, Wielgus A, Cadet J, Douki T, Mouret S, Tucker MA, Popratiloff A, Merlino G, De Fabo EC.

Nat Commun. 2012 Jun 6;3:884. doi: 10.1038/ncomms1893.

15.

Shedding light on melanocyte pathobiology in vivo.

Zaidi MR, De Fabo EC, Noonan FP, Merlino G.

Cancer Res. 2012 Apr 1;72(7):1591-5. doi: 10.1158/0008-5472.CAN-11-2586. Epub 2012 Mar 15. Review.

16.

In vivo role of alternative splicing and serine phosphorylation of the microphthalmia-associated transcription factor.

Debbache J, Zaidi MR, Davis S, Guo T, Bismuth K, Wang X, Skuntz S, Maric D, Pickel J, Meltzer P, Merlino G, Arnheiter H.

Genetics. 2012 May;191(1):133-44. doi: 10.1534/genetics.111.135996. Epub 2012 Feb 23.

17.

The two faces of interferon-γ in cancer.

Zaidi MR, Merlino G.

Clin Cancer Res. 2011 Oct 1;17(19):6118-24. doi: 10.1158/1078-0432.CCR-11-0482. Epub 2011 Jun 24. Review.

18.

A genetically engineered mouse model with inducible GFP expression in melanocytes.

Zaidi MR, Hornyak TJ, Merlino G.

Pigment Cell Melanoma Res. 2011 Apr;24(2):393-4. doi: 10.1111/j.1755-148X.2011.00832.x. No abstract available.

19.

Interferon-γ links ultraviolet radiation to melanomagenesis in mice.

Zaidi MR, Davis S, Noonan FP, Graff-Cherry C, Hawley TS, Walker RL, Feigenbaum L, Fuchs E, Lyakh L, Young HA, Hornyak TJ, Arnheiter H, Trinchieri G, Meltzer PS, De Fabo EC, Merlino G.

Nature. 2011 Jan 27;469(7331):548-53. doi: 10.1038/nature09666. Epub 2011 Jan 19.

20.

Fluorescent protein-assisted purification for gene expression profiling.

Zaidi MR, Day CP, Merlino G.

Methods Mol Biol. 2011;699:393-405. doi: 10.1007/978-1-61737-950-5_19.

PMID:
21116994
21.

From UVs to metastases: modeling melanoma initiation and progression in the mouse.

Zaidi MR, Day CP, Merlino G.

J Invest Dermatol. 2008 Oct;128(10):2381-91. doi: 10.1038/jid.2008.177. Review.

22.

Misexpression of full-length HMGA2 induces benign mesenchymal tumors in mice.

Zaidi MR, Okada Y, Chada KK.

Cancer Res. 2006 Aug 1;66(15):7453-9.

Supplemental Content

Loading ...
Support Center